Search Results - "Hennenlotter, J"

Refine Results
  1. 1

    Economic aspects of bladder cancer: what are the benefits and costs? by Sievert, K. D., Amend, B., Nagele, U., Schilling, D., Bedke, J., Horstmann, M., Hennenlotter, J., Kruck, S., Stenzl, A.

    Published in World journal of urology (01-06-2009)
    “…Objective Bladder cancer (BC) has the highest lifetime treatment costs per patient of all cancers. The high recurrence rate and ongoing invasive monitoring…”
    Get full text
    Journal Article
  2. 2

    Expression patterns of the immune checkpoint ligand CD276 in urothelial carcinoma by Aicher, Wilhelm K, Korn, M, Reitnauer, L, Maurer, F B, Hennenlotter, J, Black, P C, Todenhofer, T, Bedke, J, Stenzl, A

    Published in BMC urology (12-04-2021)
    “…CD276 is an immune checkpoint molecule. Elevated CD276 expression by urothelial carcinoma is associated with poor prognosis, but little is known about its…”
    Get full text
    Journal Article
  3. 3

    Hsa-mir-124-3 CpG island methylation is associated with advanced tumours and disease recurrence of patients with clear cell renal cell carcinoma by Gebauer, K, Peters, I, Dubrowinskaja, N, Hennenlotter, J, Abbas, M, Scherer, R, Tezval, H, Merseburger, A S, Stenzl, A, Kuczyk, M A, Serth, J

    Published in British journal of cancer (15-01-2013)
    “…Background: Whether methylation of the microRNA (mir)- 124-3 CpG island is of relevance for the clinical course of a solid cancer and whether it shows…”
    Get full text
    Journal Article
  4. 4

    Compound efficacy testing using a microplate co-culture assay comprising patient derived 3D tumor spheroids and autologous immune cells by Bodenhöfer, M, Anderle, N, Hennenlotter, J, Stenzl, A, Schmees, C

    Published in European journal of cancer (1990) (01-12-2016)
    “…An abstract of a study by Bodenhofer et al assessing compound efficacy testing using a microplate co-culture assay comprising patient derived 3D tumor…”
    Get full text
    Journal Article
  5. 5

    Prostate cancer gene 3 (PCA3) is of additional predictive value in patients with PI-RADS grade III (intermediate) lesions in the MR-guided re-biopsy setting for prostate cancer by Kaufmann, S., Bedke, J., Gatidis, S., Hennenlotter, J., Kramer, U., Notohamiprodjo, M., Nikolaou, K., Stenzl, A., Kruck, S.

    Published in World journal of urology (01-04-2016)
    “…Purpose Multiparametric magnetic resonance imaging (mpMRI) improves diagnostic accuracy in re-biopsies of men with prostate cancer (PC) suspicion, but…”
    Get full text
    Journal Article
  6. 6

    No influence of smoking status on the performance of urine markers for the detection of bladder cancer by Deininger, Susanne, Hennenlotter, J., Rausch, S., Docktor, K., Neumann, E., da Costa, I. A., Bedke, J., Stenzl, A., Todenhöfer, T.

    “…Purpose The performance of urinary markers for detecting bladder cancer (BC) is influenced by various factors. The aim of the present study was to evaluate the…”
    Get full text
    Journal Article
  7. 7

    Impact of intratumoral heterogeneity of renal cancer on drug response and development of resistance in patient derived xenografts by Zeisig, R, Flechsig, S, Wulf-Goldenberg, A, Schmees, C, Jandrig, B, Hennenlotter, J, Bedke, J, Stenzl, A, Schostak, M, Becker, M, Fichtner, I, Hoffmann, J

    Published in European journal of cancer (1990) (01-12-2016)
    “…Background: Patients with advanced renal cell carcinoma (RCC) have a poor prognosis due to fast onset of resistance towards Standard of Care (SoC) drugs…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11

    Prognostic and diagnostic relevance of hypermethylated in cancer 1 (HIC1) CpG island methylation in renal cell carcinoma by EGGERS, H, STEFFENS, S, GROSSHENNIG, A, BECKER, J. U, HENNENLOTTER, J, STENZL, A, MERSEBURGER, A. S, KUCZYK, M. A, SERTH, J

    Published in International journal of oncology (01-05-2012)
    “…The tumour suppressor gene hypermethylated in cancer 1 (HIC1) is a transcriptional repressor, which functionally cooperates with p53. Loss of HIC1 function is…”
    Get full text
    Journal Article
  12. 12

    Influence of age on false positive rates of urine-based tumor markers by Horstmann, M., Todenhöfer, T., Hennenlotter, J., Aufderklamm, S., Mischinger, J., Kuehs, U., Gakis, G., Stenzl, A., Schwentner, C.

    Published in World journal of urology (01-08-2013)
    “…Introduction Several influencing factors on false positive rates (FPRs) of urine-based tumor markers in the detection of urothelial cancer (UC) have been…”
    Get full text
    Journal Article
  13. 13

    CD147, The Ancillary protein of MCT4, as marker for prognosis and clinical outcome in primary clear cell renal cell Carcinoma and Metastasis by Fisel, P, Stühler, V, Winter, S, Rausch, S, Hennenlotter, J, Nies, A.T, Stenzl, A, Scharpf, M, Fend, F, Kruck, S, Bedke, J, Schwab, M, Schaeffeler, E

    Published in Clinical therapeutics (01-08-2015)
    “…Just as previously demonstrated for MCT4, CD147 is proposed to be associated with tumor progression and metastasis in clear cell renal cell carcinoma (ccRCC)…”
    Get full text
    Journal Article
  14. 14

    Prostatic peripheral nerve distribution may impact the functional outcome of nerve-sparing prostatectomy by Amend, B., Hennenlotter, J., Kuehs, U., Laible, I., Anastasiadis, A., Schilling, D., Stenzl, A., Sievert, K. D.

    Published in World journal of urology (01-04-2013)
    “…Purpose To study microscopic patterns of remaining peripheral nerves (PN) after nerve-sparing (NS) radical prostatectomy (RP) and possible consequences for…”
    Get full text
    Journal Article
  15. 15

    Influence of body mass index, surgical approach and lymphadenectomy on the development of symptomatic lymphoceles after radical prostatectomy by Mundhenk, J, Hennenlotter, J, Alloussi, S, Selbherr, D, Martzog, J C, Todenhöfer, T, Kruck, S, Schwentner, C, Stenzl, A, Schilling, D

    Published in Urologia internationalis (01-01-2013)
    “…Identification of factors influencing lymphocele formation requiring intervention after radical prostatectomy. 302 patients undergoing radical retropubic…”
    Get more information
    Journal Article
  16. 16

    Alteration of bone sialoprotein expression in osseous metastasized renal cell carcinomas and the tumor surrounding tissue by Mittag, F., Hennenlotter, J., Minkley, L., Ipach, I., Schilling, D., Scharpf, M., Stenzl, A., Leichtle, U., Kluba, T.

    Published in Clinical & experimental metastasis (01-02-2012)
    “…Bone sialoprotein (BSP) regulates bone metabolism by directly influencing the activity of osteoblasts and osteoclasts. A significant correlation between the…”
    Get full text
    Journal Article
  17. 17

    Kidney-specific cadherin correlates with the ontogenetic origin of renal cell carcinoma subtypes: an indicator of a malignant potential? by Horstmann, M., Geiger, L. M., Vogel, U., Schmid, H., Hennenlotter, J., Kuehs, U., Merseburger, A. S., Kruck, S., Stenzl, A., Bedke, J.

    Published in World journal of urology (01-08-2012)
    “…Introduction and objectives To evaluate retrospectively kidney-specific cadherin (Ksp-cad) expression in renal cell carcinoma (RCC) subtypes and oncocytoma in…”
    Get full text
    Journal Article
  18. 18

    Akt signalling parameters are different in oncocytomas compared to renal cell carcinoma by Amend, B., Hennenlotter, J., Scharpf, M., Kruck, S., Kuehs, U., Senger, E., Merseburger, A. S., Kuczyk, M. A., Sievert, K. D., Stenzl, A., Bedke, J.

    Published in World journal of urology (01-06-2012)
    “…Purpose Renal oncocytomas are assigned as benign tumours, and their detailed molecular mechanism is poorly characterised. Activation of the PKB/Akt pathway is…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Blended E-learning in a Web-based virtual hospital: a useful tool for undergraduate education in urology by Horstmann, M, Renninger, M, Hennenlotter, J, Horstmann, C C, Stenzl, A

    Published in Education for health (Abingdon, England) (01-08-2009)
    “…E-learning is a teaching tool used successfully in many medical subspecialties. Experience with its use in urology, however, is scarce. We present our teaching…”
    Get more information
    Journal Article